Global Screening for Liver Cancer Supply, Demand and Key Producers, 2023-2029

Global Screening for Liver Cancer Supply, Demand and Key Producers, 2023-2029

The global Screening for Liver Cancer market size is expected to reach $ 14300 million by 2029, rising at a market growth of 6.9% CAGR during the forecast period (2023-2029).

Globally, liver cancer is one of the leading causes of cancer-related deaths. According to the American Cancer Society, the incidence of liver cancer has tripled since the 1980s, and the death rate has now doubled. In the United States, about 41,260 new cases are expected to be diagnosed, while about 30,520 deaths from liver cancer are expected, according to 2022 cancer statistics. The global prevalence of liver cancer and the continuous exposure of related populations to risk factors will rapidly drive the screening and diagnostics market.

Screening for Liver Cancer

This report studies the global Screening for Liver Cancer demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Screening for Liver Cancer, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Screening for Liver Cancer that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Screening for Liver Cancer total market, 2018-2029, (USD Million)

Global Screening for Liver Cancer total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Screening for Liver Cancer total market, key domestic companies and share, (USD Million)

Global Screening for Liver Cancer revenue by player and market share 2018-2023, (USD Million)

Global Screening for Liver Cancer total market by Type, CAGR, 2018-2029, (USD Million)

Global Screening for Liver Cancer total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Screening for Liver Cancer market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Thermo Fisher Scientific, Inc., Berry Oncology, New Horizon Health, BGI, GTH.O, Livzon, BNR.O and SingLera, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Screening for Liver Cancer market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Screening for Liver Cancer Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Screening for Liver Cancer Market, Segmentation by Type
Hematology Test
Imaging Test

Global Screening for Liver Cancer Market, Segmentation by Application
Hospital
Clinic
Other

Companies Profiled:
Abbott Laboratories
Thermo Fisher Scientific, Inc.
Berry Oncology
New Horizon Health
BGI
GTH.O
Livzon
BNR.O
SingLera
Fujifilm Medical Systems U.S.A., Inc.
F. Hoffmann-La Roche Ltd.
Siemens Healthineers
BD
Illumina, Inc.
Epigenomics AG

Key Questions Answered

1. How big is the global Screening for Liver Cancer market?

2. What is the demand of the global Screening for Liver Cancer market?

3. What is the year over year growth of the global Screening for Liver Cancer market?

4. What is the total value of the global Screening for Liver Cancer market?

5. Who are the major players in the global Screening for Liver Cancer market?

6. What are the growth factors driving the market demand?